- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Second Chance for NIH Grant Applicants
10 February 2011 5:10 pm
Did you miss the funding cutoff despite a stellar score on your U.S. National Institutes of Health (NIH) grant? Don't give up hope. The National Health Council (NHC), a Washington, D.C.-based nonprofit umbrella group for some 100 patient-advocacy groups and companies, unveiled a database on Monday that will hook up rejected projects and potential funders.
The site, called Health Research Funding, is meant to be "the Match.com of funding organizations," says NHC spokesperson Emily Noonan. Any researcher who had a proposal that NIH deemed worthy of peer review but didn't fund can post their abstract and contact information for no cost. Registered funding organizations (but no one else) will be able to troll the abstracts for projects they like.
Right now, the site has info from just the 42 patient-advocacy groups, such as the American Cancer Society and the Alzheimer's Association. Companies may be added later, possibly for a fee, says Nancy Hughes, NHC assistant vice president for communications and marketing.
NHC proposed the database more than 3 years ago, but it took a while to round up the funding ($112,000 split roughly between Pfizer and NIH) and to build the database, Hughes says. On her blog, NIH extramural researcher chief Sally Rockey called it "good news on the where-am-I-going-to-get-my-grant-funded-in-today's-economy front."